What Are the Best Treatments for Bladder Dysfunction in MS?

Suggested Reading

Ginsberg D, Gousse A, Keppenne V, et al. Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity. J Urol. 2012;187(6):2131-2139.

Jongen PJ, Blok BF, Heesakkers JP, et al. Simplified scoring of the Actionable 8-item screening questionnaire for neurogenic bladder overactivity in multiple sclerosis: a comparative analysis of test performance at different cut-off points. BMC Urol. 2015;15:106.

Wintner A, Kim MM, Bechis SK, Kreydin El. Voiding dysfunction in multiple sclerosis. Semin Neurol. 2016;36(1):34-40.